1. The Importance of Dopamine D₄ Receptors in the Action and Development of Antipsychotic Agents

   • Gavin P. Reynolds

   Leading Article 31 October 2012 Pages: 7 - 11

2. The Clinical Potential of Endothelin Receptor Antagonists in Cardiovascular Medicine

   • Charles J. Ferro
   • David J. Webb

   Review Article 31 October 2012 Pages: 12 - 27

3. Amyotrophic Lateral Sclerosis

   • Barry W. Festoff

   Review Article 31 October 2012 Pages: 28 - 44

4. Emerging Drug Treatments for Solid Tumours

   • Jan H. M. Schellens
   • Linda C. Pronk
   • Jaap Verweij

   Review Article 31 October 2012 Pages: 45 - 72

5. Head and Neck Cancer

   • Gilles Catimel

   Disease Management 31 October 2012 Pages: 73 - 88

6. Current Guidelines for the Treatment of Congestive Heart Failure

   • Franz X. Kleber
   • Roland Wensel

   Disease Management 31 October 2012 Pages: 89 - 98

7. Imipenem/Cilastatin

   • Julia A. Balfour
   • Harriet M. Bryson
   • Rex N. Brogden

   Drug Evaluation 31 October 2012 Pages: 99 - 136

8. Enoxacin

   • Sanjay S. Patel
   • Caroline M. Spencer

   Drug Evaluation 31 October 2012 Pages: 137 - 160

9. Erratum to Doxazosin: an update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia

   • B. Fulton
   • A. J. Wagstaff
   • E. M. Sorkin

   Erratum 31 October 2012 Pages: 160 - 160

10. Clarithromycin and Omeprazole

    • Anthony Markham
    • Donna McTavish

    Drug Evaluation 31 October 2012 Pages: 161 - 178